论文部分内容阅读
目的:探讨营养干预辅助药物三联法(硝苯地平控释片、酚妥拉明和硫酸镁)用于妊娠高血压的疗效探究。方法:收集2012年3月至2014年12月来我院就诊的妊娠高血压患者220例,随机分为试验组和对照组,每组110例。试验组给予硝苯地平控释片、酚妥拉明和硫酸镁常规药物三联法治疗;对照组给予常规硫酸镁治疗;并且两组患者均给予营养干预。结果:两组患者治疗后收缩压和舒张压下降水平和并发症发生率均小于对照组,而治疗有效率高于对照组,分别经t检验或卡方检验,差异均有统计学意义(P<0.05)。结论:营养干预辅助药物三联法(硝苯地平控释片、酚妥拉明和硫酸镁)治疗妊娠高血压具有显著的临床疗效。
Objective: To investigate the efficacy of triple therapy (nifedipine controlled release tablets, phentolamine and magnesium sulfate) for pregnancy induced hypertension. Methods: A total of 220 cases of pregnancy-induced hypertension in our hospital from March 2012 to December 2014 were collected and randomly divided into experimental group and control group with 110 cases in each group. The experimental group was given nifedipine controlled release tablets, phentolamine and magnesium sulfate conventional drugs triple therapy; control group given conventional magnesium sulfate treatment; and both groups were given nutritional intervention. Results: After treatment, systolic blood pressure and diastolic blood pressure decreased and complications were lower in both groups than those in the control group, but the treatment efficiency was higher than that in the control group. There was significant difference between the two groups by t-test or chi-square test (P <0.05). Conclusion: The triple therapy of nourishment intervention (Nifedipine GITS, Phentolamine and Magnesium Sulfate) has significant clinical effect in treating pregnancy induced hypertension.